Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-04-20
1998-03-24
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 23, 514866, 536 41, A61K 3170
Patent
active
057312923
ABSTRACT:
A method for prophylaxis or treatment of diabetes, which comprises administering to a patient with diabetes an effective amount of a ##STR1## wherein Ar is an aryl group, R.sup.1 is hydrogen atom or an acyl group, R.sup.2 is a hydrogen atom, an acyl group or .alpha.-D-glucopyranosyl group, or R.sup.1 and R.sup.2 may combine together to form a substituted methylene group, R.sup.3 and R.sup.4 are each a hydrogen atom or an acyl group, OR.sup.5 is a protected or unprotected hydroxy group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 3984394 (1976-10-01), Westall et al.
patent: 4031260 (1977-06-01), Westall et al.
patent: 4665058 (1987-05-01), Deidrich et al.
patent: 4684627 (1987-08-01), LeVeen et al.
patent: 4760135 (1988-07-01), Diedrich et al.
patent: 4840939 (1989-06-01), LeVeen et al.
patent: 5110801 (1992-05-01), LeVeen et al.
patent: 5424406 (1995-06-01), Tsujihara et al.
D. Diedrich (1963) Biochim. Biophys. Acta, (71) 688-700.
Rosetti et al. (1990) Diabetes Care 13(6), 610-630.
Rosetti et al. (1987) J. Clin. Invest. (79) 1510-1515.
Rosetti et al. (1987) J. Clin. Invest. (80) 1037-1044.
Kahn et al. (1991) J. Clin. Invest (87) 561-570.
Unger et al. (1985) Diabetologia 28:119-121.
Olendorf et al. (1983) Stroke (14) 388-393.
Winget et al. (1969) Biochemistry (8) 2067-2074.
Vick et al. (1973) Am. Journal of Physiology 224 (3) 552-557.
D. Diedrich (1966) Ar. of Biochem. and Biophy. 117:248-256.
Evans et al. (1980) Ar. of Biochem. and Biophy. 199(2) 342-348.
Bode et al. (1972) Biochim. Biophys. Acta, 290 134-149.
Pzabo et al., Acta Alimentaria, vol. 11 (1), pp. 31-37.
Unger et al., Diabetologia, 28 (1985), 119-121.
"Guidelines for Toxicity Studies of Drugs," Ministry of Health and Welfare of Japan, 114-118.
Fujiwara et al., Diabetes, (37) (1988) 1549-1558.
Dorland's Medical Dictionary, 27 ed., pp. 460-461 (1988).
Odaka et al., J. Nutr. Sci. Vitaminol, 38 (1992) Abstract.
Arakawa Kenji
Funami Nobuyuki
Hongu Mitsuya
Inamasu Masanori
Tsujihara Kenji
Kight John
Lee Howard C.
Tanabe Seiyaku Co. Ltd.
LandOfFree
Dihydrochalcone derivatives which are hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydrochalcone derivatives which are hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrochalcone derivatives which are hypoglycemic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2288982